Oral vaccines are a type of vaccine that is taken orally, usually in the form of a pill or liquid solution. They are designed to help the body develop immunity against diseases by introducing a weakened or killed version of the disease-causing microorganism. Oral vaccines are usually safer than injectable vaccines and can provide protection against a wide variety of illnesses, including polio, rotavirus, and cholera.
Oral vaccines are increasingly being used in many countries around the world to help reduce the burden of infectious diseases. The World Health Organization (WHO) recommends the use of oral vaccines in areas where access to injectable vaccines may be limited. It is estimated that more than 80 percent of children in the world have received an oral vaccine in the past year.
Oral vaccines can be used to immunize populations in developing countries that may not have access to medical services, and they can also be used to supplement existing immunization programs. In addition, oral vaccines are more cost-effective than injectable vaccines and may be less likely to cause side effects.
The global Oral Vaccines market was valued at US$ 2474 million in 2022 and is anticipated to reach US$ 3333.6 million by 2029, witnessing a CAGR of 4.3% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
A detailed market research report on Global Oral Vaccines Market available at: https://www.themarketreports.com/report/global-oral-vaccines-market-research-report
This report aims to provide a comprehensive presentation of the global market for Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccines.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Ask for more details or sample of this report at: https://www.themarketreports.com/report/ask-your-query/1410188
The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479